High-dose Benda-EAM versus BEAM in patients with relapsed/refractory classical Hodgkin lymphoma undergoing autologous stem cell transplantation.

Erica S TsangDiego R VillaFederica LoscoccoGiuseppe VisaniMaryse PowerBarbara GuiducciCristina ClissaKevin SongCynthia TozeYasser Abou MouradHeather SutherlandDavid SanfordStephen H NantelLaurie H SehnDavid W ScottKerry J SavageJoseph M ConnorsAlina S GerrieAlessandro Isidori

Published in: Bone marrow transplantation (2018)

Keyphrases

hodgkin lymphoma
stem cell transplantation
high dose
low dose
cell therapy
platelet rich plasma
stem cells
acute lymphoblastic leukemia